Previous studies have indicated that SNHG16 promotes tumor development through EMT and predicts poor survival outcomes in several cancers (Cao, Xu, and Yue, 2018; Bu, Guo, Xu, Luo, and Liu, 2021). The gene discussed is SNHG16; the disease is neoplasm.